1

TABLE OF CONTENTS

2ND

YEAR BDS

Sr.No. Content Page No.

1 Term-I 3

2 Term-II 8

3 List of Practicals 14

4 List of tutorials 15

5 Reference Books 16

6 Table of specification

Pre-Annual/Annual 2nd

Professional

Examination: Theory

17

7 Table of specification

Pre-Annual/Annual 2nd

Professional

Examination: Practical

18

8 Annual Academic Calendar 19

9 Weekly Training Program 20

2

Study Guide

2nd year BDS

Pharmacology &

Therapeutics

CMH Lahore Medical College & Institute

of Dentistry

3

No

Topic

Mode of

Information

Transfer

Learning Objectives

1.

Pharmacology:

Introduction,

Historical overview.

Lecture

Introduction of pharmacology dept/faculty

Forecast of activities in full academic year

Training modules

Forecast of academic landmarks

Definition of pharmacology and relevant

discussion/historic overview

Rational drug therapy

Role of Muslims scientist in advancement of

pharmacology

Modern pharmacology

2.

Pharmacology:

Branches/division of

Pharmacology, Role in

Medicine

Lecture

Definitions of: Pharmacokinetics,

pharmacodynamics, therapeutics,

chemotherapy, toxicology, clinical

pharmacology, Pharmacy, pharmacognosy,

pharmacokinetics, pharmacogenomics,

pharmacoepidemiology, comparative

pharmacology, animal pharmacology,

pharmacoeconomics, posology

3. Active Principles of

Drugs Lecture Definition; Characteristics with examples

4. Dosage forms &

doses of drugs Lecture

Definition; explanation with examples of

various dosage forms

5. Routes of drug

administration Lecture

Definition; Explanation and examples of

various routes of administration of drugs

6. Absorption of drugs:

processes Lecture

Definition, Processes, Factors affecting

Absorption of Drugs 7.

Factors modifying

drug absorption. Lecture

8.

Distribution and

plasma protein

binding of drugs,

drug reservoirs

Lecture

Definition, Inter relationship among

distribution, absorption, metabolism and

elimination of drug, factor affecting drug

distribution, PPB clinical significance, drug

reservoirs, volume of distribution, clinical

significance over dosing regimens, loading

dose, factor affecting Volume of

distribution

4

9. Biotransformation of

drugs.

Lecture

Definition/aims and types of reactions

involved in conversion of drugs into

metabolites for excretion

10. Factors modifying

biotransformation Lecture

Explaining the factors that influence the

biotransformation of drugs

11.

Bioavailability: clinical

significance and factors

affecting.

Lecture

Definition, factors affecting bioavailability of

drugs, Significance, Bioequivalence,

Therapeutic equivalence, Chemical

equivalence

12.

Half-life of drugs:

factors affecting and

clinical significance.

Lecture

Definition, formula, phases, graphical

representation, factors affecting half-life,

significance, examples

13.

Excretion of drugs.

Drug clearance,

Lecture

Definition/ routes of excretion, Processes

involved in renal excretion of drugs,

Glomerular function of GFR, Tubular

secretion of drugs, Tubular reabsorption of

drugs, Elimination of drug by the liver,

Minor routes of elimination of drugs, Drug

clearance

14. Mechanism of drug

action-I Lecture Definition, receptors, types, agonist

/antagonist, mechanisms, signaling

mechanism, second messenger system 15. Mechanisms of drug

action – II Lecture

16.

Factors modifying

actions & doses of

drugs – I

Lecture

Age, idiosyncratic reaction, hypersensitivity,

genetic, drug antagonism, Tolerance and

synergism etc

17.

Factors modifying

actions & doses of

drugs – II

Lecture

18. A N S : Introduction-I

Lecture

Parasympathetic NS, synthetic, release

transport of NT cholinoceptors.

Sympathetic NS, synthesis, release

transport of NT adrenoceptors

19.

A N S : Introduction-II

20. Catecholamines – I

Adrenaline. Lecture

Definition, receptors, classification,

chemistry, metabolism, MoA of adrenaline,

receptors, pharmacological action on all

organ systems, therapeutic uses. NE,

receptors, pharmacokinetics, MoA, organ

system effects, therapeutic uses, adverse

effects. Isoprenaline, dopamine,

dobutamine, (MoA, organ system effects,

Pharmacokinetics, adverse effects,

therapeutic uses)

21.

Catecholamines – II Nor

adrenaline, Dopamine

& Dobutamine.

Lecture

22. Non Catecholamines:

Ephedrine,

Lecture

Comparison of catecholamines and non

catecholamines, ephedrine, amphetamine,

phenylephrine, salbutamol tyramine

5

Amphetamines α receptor agonists etc.

,dexmedetomideine, xylometazoline and

oxymetazoline (MoA, organ system effects,

Pharmacokinetics, adverse effects,

therapeutic uses).

23.

Adrenergic Blockers.

Alpha- receptor

Blockers.

Lecture Classification, therapeutic indications, untoward

effects

24.

Adrenergic Blockers:

Beta receptor

Blockers – I.

Lecture

Postsynpatic receptors, presynaptic, beta

receptors actions, classification,

pharmacokinetics, pharmacological actions,

therapeutic uses, adverse effects,

contraindication 25.

Beta Receptor

Blockers- II Lecture

26. Central

Sympathoplegics. Lecture

α methyl dopa, Clonidine, Apra clonidine,

Guanfacine (MOA, Uses, Adverse effects)

27.

Cholinergic drugs.

Classification,

Cholinesters,

alkaloids etc.

Lecture

Classification, Cholinoceptors, MOA,

Pharmacological action, Therapeutic uses, A/E,

PK Salient features of individual drugs

(carbachol, Methacholine, Bethanechol,

Neostigmine, Physostigmine). Diff btw

Neostigmine &Physostigmine Myasthenia

gravis. Clinical features & Rx.

Organophosphate Poisoning & clinical

features, Acute & Chronic nicotinic toxicity and

treatment

28. Anti Cholinesterases. Lecture

29.

Organophosphate

poisoning & Oximes.

Lecture

30.

Cholinergic blockers;

Natural alkaloids.

Comparison between

Hyoscine & Atropine.

Lecture

Drug interaction, receptors, classification,

chemical, therapeutic classification,

pharmacokinetics, Mechanism of action,

pharmacological action, therapeutic uses

31. Semisynthetic

Anticholinergics. Lecture

32. Skeletal Muscle

Relaxants-I Lecture

Peripherally acting; Non depolarizing

neuromuscular blockers (isoquinoline

derivatives, steroid derivatives) Depolarizing

neuromuscular blockers, Centrally acting;

Benzodiazepines, Gaba analogues,

Propanediolderivatives, Misc compounds,

Directly acting; Dantrolene

33.

Skeletal Muscle

Relaxants-II

Lecture

34. Central

Neurotransmission Lecture

Types of ion channels, Neurotransmitters

35.

Gen Anaesthetics – I,

Classification, Method

of administration,

Pharmacokinetics of

Lecture

Definition, Gen principles of surgical

anesthesia, preanesthetic medications,

classification and types of G. A. stages of

anesthesia, inhalation anesthetic, mode of

delivery of inh. Anesthetics,

6

inhalational

Anaesthetics

pharmacokinetic characters, affecting

induction and recovery. Mechanism of

action, individual agent with their specific

uses and untoward reaction I/V anesthetic.

Comparative studies of advantages and

disadvantages of individual agent.

36.

Gen Anaesthetics-II,

Pre- anaesthetic

medication, Stages of

Anaesthesia,

Mechanism of action

Lecture

37.

General

Anaesthetics-III,

Volatile liquids

Lecture

38.

General

Anaesthetics-IV,

Gases

Lecture

39.

General

Anaesthetics-V,

Intravenous

anesthetics

Lecture

40. Local Anaesthetics-I Lecture Physiology of pain, Chemistry of LA,

Classification to acidity Therapeutic uses

/chemical & Duration of action MOA/

Factors affecting LA action Advantages of

addition of Vasoconstriction Differential

Sensitivity of nerve fibers to LA P/K, salient

features of Lignocaine & Spinal Analgesia &

A/E & uses. How to prevent toxicity of LA.

41. Local Anaesthetics-II Lecture

42.

Local Anaesthetics-IIL

Lecture

43.

Sedative & Hypnotics

– I Introduction &

Classification

Lecture

Introduction and classification,

Benzodiazepines, mechanism of action,

clinical uses, adverse effects, Buspirone,

zolpidemzaleplon, Clinical uses of

barbiturates uptodate

44.

Sedative & Hypnotics

–II Barbiturates

Lecture

Introduction and classification,

Benzodiazepines, mechanism of action,

clinical uses, adverse effects, Buspirone,

zolpidemzaleplon, Clinical uses of

barbiturates uptodate

45.

Sedative &

Hypnotics- III.

Benzodiazepines.

Lecture

46.

Antiepileptic drugs-I

.Classification,

hydantoin

derivatives,

Lecture

Introduction, type of seizures and

classification of drugs, Carbamazepine, valproic

acid, Barbiturates, succinimides,

benzodiazepines and newer drugs

7

47.

Antiepileptic drugs-

II. Carbamazepine,

valproic acid.

Lecture

48.

Antiepileptic drugs-

III. Barbiturates,

succinimides,

Benzodiazepines, Newer

drugs

Lecture

49.

Anti-depressants

Introduction and

Classification

Lecture

Salient features of Depression, Classification

SSRI,S, SNRIP/K, A/Es

50.

Drugs treatment of

Migraine.

Lecture

Classification and

phatmacokinetics/pharmacodynamics of drugs

used in treatment of migraine

51.

Analgesics –I:

Introduction,

Classification

Lecture

Introduction and classification, Semi

synthetic/synthetic, opioids and opioid

analgesic, Therapeutic uses, adverse effects and

contraindication

52.

Analgesics;-II

Morphine

Lecture

53.

Analgesics – III:

Semisynthetic/

synthetic opioids &

opioid antagonists

Lecture

54.

NSAIDs:

Classification,

Mechanism of Action.

Lecture

Non Selective cyclo-oxygenase Inhibitors,

Cyclo-oxygenase-2 Selective Inhibitors,

MOA, Uses, Adverse effects, Aspirin,

Paracetamol (Pharmacokinetics, MoA,

clinical uses, adverse effects).

55.

Aspirin & other

Salicylates.

Lecture

56.

Propionic acid, Acetic

acid der. &

Paracetamol

Lecture

8

Term-2

57. Physiology of Heart Lecture Electrophysiological properties of heart,

types of heart failure, physiological

mechanism in heart failure, classification of

drug used in heart failure, cardiotonic drugs

Digoxin, bipyridines&

resynchronization therapy.

58. Drugs used in CCF-l Lecture

59. Drugs used in CCF-ll

60. Anti anginal drugs Lecture Types of angina, Organic Nitrates, Calcium

Channel Blockers, Beta

antagonists,Potassium channel Activators,

Newer Anti anginal Drugs. Drugs used in

management of IHD/MI.

61.

Drug Treatment of MI

Lecture

62.

Antihypertensive drugs-

I Sympatholytic drugs.

Lecture

Diuretics, sympatholytics, calcium channel

blockers, drugs acting on renin angiotensin

system, vasodilators

63.

Antihypertensives drugs-

II Diuretics. Ca++ Channel

blockers.

Lecture

64.

Antihypertensives drugs-

IIl. ACE inhibitors, AT

receptor Antagonist

Directly acting

vasodilators

Lecture

65.

Anti arrhythmic drugs

Lecture

Normal electrophysiology of heart,

mechanism of and types of arrhythmias,

mechanism of drug action in arrhythmias,

classification of drugs, Class-I

antiarrhythmic (Na+ channel blockers),

Class-II drugs (beta blockers) class-III drugs (K+

channel blockers) class-IV drug (Ca+2 channel

blockers), Misc (digoxin, adenosine, Mg2+&

K+) comparison of all groups, treatment of

important

arrhythmias.

66.

Diuretics: Introduction,

Classification.

Lecture

Physiology of Nephron, Classification, CAI (PK,

MOA, Uses, A/E, C/I, Drugs Interaction),

Loop Diuretics, Thiazides, K+ sparing,

Osmotic Diuretics, ADH antagonists (Names

& Salient features)

67. Diuretics: Thiazides. Lecture

68.

Diuretics: Loop. K+

sparing, Osmotic &Misc

groups,

Lecture

Term Test-1

9

69.

Introduction, General

Principles of

Chemotherapy,

Lecture

Def, antimicrobial antibiotics,

bacteriostatic, bactericidal, conc and time

dependent killing, post antibiotic effect,

narrow, extended & broad spectrum

antibiotics. Ten principles of

chemotherapy, classification of

antimicrobials

70.

Mechanism of Resistance

Lecture

Innate, acquired resistance, due to genetic

alteration and altered expression protein and

their mechanisms, single step

mutation,Multi-step mutation, cross

resistance, complete & Partial cross

resistance. Prevention of resistance.

71. Sulfonamides Lecture Historic overview, Chemistry of

sulfonamides/MoA, Classification, PK/PD &

toxicities/uses, Sulfonamides combinations,

Cotrioxazole, Trimethoprim/sulfonamides,

PK/PD, uses &

toxicity of co-trimoxazole

72.

Trimethoprim &

Cotrimoxazole

Lecture

73. Antibiotics, Penicillins. Lecture Classification, structure, mechanism of

action, mechanism of resistance,

pharmacokinetics, Dose, therapeutic uses &

adverse effects.

74.

Antibiotics, Penicillins –

Semisynthetics.

Lecture

75.

Antibiotics,

Cephalosporins.

Lecture

Classification, structure, spectrum, P/K

(Pharmacokinetics), mechanism of action,

therapeutic uses, A/E

76.

Macrolides. Antibiotics:

Broad spectrum

Lecture Spectrum/clinical uses adverse effects,

mechanism of action & resistance

77.

Antibiotics: Broad

spectrum, Tetracyclines.

Lecture

Classification, Phamacokinetics of

Tetracycline, Spectrum of activity, MOA &

resistance, A/Es, Therapeutic Uses, Drug

Interaction & Contraindications

78. Chloramphenicol. Lecture Spectrum, clinical uses, adverse effect and

MOA & resistance

79.

Antibiotics:

Aminoglycosides

Lecture

MoA, PK, uses and untoward reaction

80. Quinolones. Lecture MoA, PK, classification, uses, spectrum and

untoward reactions.

81.

Antituberculosis drugs –

I.

Lecture

Introduction, Features of mycobacterium TB,

classification, First line drugs, structure,

mechanism of action, therapeutic uses,

adverse effects. Dose, (contraindications)2nd

line drugsStructure,

mechanism of action, therapeutic uses,

82.

Antituberculosis drugs –

II.

Lecture

10

Adverse effects, dose, MAC, Definition,

introduction, treatment, DOT, WHO

recommended regimens

83. Anti fungal drugs-I Lecture Classification, spectrum of individual class,

MoA, uses, PK and untoward action. 84. Anti fungal drugs-II Lecture

85. Anti viral drugs –I Lecture Structure, life cycle, classification, acyclovir,

valacyclovir, famciclovir, penciclovir,

gancicloverfoscarnet, cidofovir, (MoA,

pharmacokinetics, therapeutic uses, adverse

effects). Amantadine, rimantadine,

zanamiviroseltamivir, ribavirin, antiretroviral

agents, NRTIS,NNRTIS, Protease inhibitors,

fusion inhibitors, integrase inhibitors, drug

treatment of hepatitis C (interferon ribavirin,

sofosbovir) drug treatment of hepatitis B,

(Lamivudine,

adefovir, telbivudine, )

86.

Anti viral drugs II.

Lecture

87.

Anti Malarial

Lecture

Species/life cycle of plasmodium, Malaria

symptoms, Therapeutic classification,

Chemical classification,

ChloroquineMoA/PK/PD/uses; Quinine

MoA/PK/PD/uses;

Mefloquine/Primaquine/atovaquone,

Lamofantrine, Drugs used in chloroquine

resistant malaria, Chemoprophylaxis of

malaria

88. Anti Amoebics-I Lecture Amoebiasis, life cycle of

entamoabahistolytica , pathogenesis,

classification, mechanism of action, P/K,

Pharmacodynamics, spectrum, dose,

adverse effects, contraindication, regimens

89.

Anti Amoebics-II

Lecture

90.

Antineoplastics Therapeutic

classification.

Alkylating agents

Antimetabolites, Vinca

alkaloids, antibiotics

and hormones.

Chemotherapeutic agents

used in dentistry

Lecture

Classification, antimetabolites,

methotrexate (MoA, PK, Therapeutic uses,

adverse effect resistance, Purine

antagonism, 6-mecptopurine,

thioguaninePyrimidine, antagonist,

5Flurouracil, Cyclophosphamide,

nitrosoreas, platinum analogs, vinca

alkaloids, taxanes, and related

drugs.Epipodophyllotoxins, (Etoposide,

teniposide, anthracyclines, monoclonal

antibodies, hormones, antihormones).

11

91.

Antidiabetic drugs:

Introduction

Classification,

Lecture

Overview of DM/Sign symptoms, Types of DM,

Insulin Structure/releaseClassification/

Pharmacokinetics, MOA, Method of

administration, clinical condition when Insulin

to be uses, DKA Pathophysiology & Rx

overview, A/Es of Insulin, How to manage

Hypoglycemia, Oral Ant diabetic Drugs

Classification, Pharmacokinetics & Most uses

A/Es of Sulfonylureas/Biguinides/Thiazide

diuretics

Meglitinide / Nateglimide

92.

Antidiabetic drugs:,

Insulins, Oral antidiabetic

agents

Lecture

93. Antithyroid drugs-l Lecture Thyroid, MoA of thyroxine, S/S of

hyperthyrodism, hypthyrodism,

Pharmacokinetics of thyroxine, Levo,

liothyroxine, liotrx, therapeutic uses.

Classification, thioamides, anion inhibitor,

iodides, radioactive, iodine iodinates,

contrast media, beta blockers,

management of thyroid storm.

94.

Antithyroid drugs-ll

Lecture

95.

Corticosteroids-I Lecture Synthesis, release, feedback , mechanism, HPA,

classification, P/K, Pharmacodynamics,

adverse effects, dose. Corticosteroids-II Lecture

96.

Hormonal contraceptives.

Lecture

Types and doses and classification,

mechanism of action, pharmacological

actions, adverse effects, benefits,

contraindications.

97.

Haematinics

Lecture

How to diagnose & different b/w Microcytic

& Macrocytic anemia, Iron absorption

Physiology, Iron Storage, transport,

elimination, Factor affecting absorption,

Therapeutic Indications, A/Es, Preparation &

Content of Iron, VB12 Folic acid absorption /

distribution / transports / Storage, Essential

biochemical reactions Req VB12 & Folic acid,

Consequence of VB12 & Folic acid,

Erythropoietin, Different

Preparations, Indication of use

98.

Anticoagulants.

Introduction,

Classification. Heparin.

Lecture

Physiology of coagulation (coagulation

cascaded), pathology of thrombosis,

(Predisposing conditions), structure of clot,

structure of thrombus, classification,

parenteral agent (heparin, low molecular

weight heparins, heparinoids, direct acting

agents, fondaparinux, oral agent (warfarin)

direct acting agent.

99.

Oral Anticoagulants.

Lecture

12

100.

Thrombolytic,

Antiplatelet drugs

Lecture Classification, mechanism of action, dose,

therapeutic uses, adverse effects.

101.

Anti emetics.

Lecture

Gastrointestinal motility/enteric

nervous system, Nausea &

vomiting/summary of events, Emetic -

-----/CTZ/receptors involved Input/out

of emetic, Classification of antiemetic

drugs, metoclopramide/domperidone,

Ondanstrone/5-HT receptors

antagonists Cannabinoid receptor

antagonist/dronabinol, NK/ receptor

antagonist /Aprepitant, Misc

agents/corticosteroids/antiemetics

102.

Antidiarrhoeals.

Lecture

Definition/clinical cause/types of

diarrhea,

Pathophysiology/complication of

diarrhea, Management of

mild/moderate/severe diarrhea, ORS

and role of antibiotics/ I/V rehydration,

Antidiarrheal classification,

Diphenoxylate PK/PD, uses, Operamide

PK/PD,uses, Bismuth

subsalicylate/methylcellulose/

ispaghula husk, Kaolin &

pectin/attapulgite,

Octreotide PK/PD & uses/MoA

103.

Purgatives/laxatives.

Lecture

Definition of constipation, Causes of

constipation, Classification of

purgatives, Bulk purgatives/MoA,

Stimulant purgatives/MoA, Osmotic

laxatives/MoA,

Stool softness, 5-HT4 agonists/MoA

104.

Drugs used in Peptic

Ulcer – I.

Lecture

Antacids, H2 receptor antagonist,

proton pump inhibitors, Mucosal

protective sucaralfateetc

105.

Drugs used in Peptic

Ulcer – II.

Lecture

13

106.

Expectorants &

Antitussives.

Lecture

Cough, pathophysiology, classification,

therapeutic uses, opioids, derivatives,

pholcodine, dextromethorphane,

levopropoxyphene, antihistamines,

peripheral antitussives,

bronchodilatation,

mucokinetics, expectorants.

107. Antiasthmatics– I. Lecture Definition/epidemiology/etiology of

asthma, Atopy/allergy and

pathophysiology of asthma,

Symptoms/diagnosis /types of asthma,

Asthma severity classification,

Classification of Antiasthmatics drugs,

Approach to treatment of asthma,

Asthma

108.

Antiasthmatics – II.

Lecture

control assessment,

Bronchodilators/sympathomimetic drugs,

Methylxanthines, Anticholinergic drugs,

Leukotriene receptor antagonists, Mast cell

stabilizer & corticosteroid, Management of

severe acute asthma

109.

Antihistamines

Lecture

Classification, Pharmacokinetics,

Pharmacodynamics, Diff b/w 1st and 2nd

generation, uses, adverse effects.

110.

Antiseptics and

Disinfectants used in

dentistry

Lecture

Classification with explanation of drugs and

their clinical relevance

111. Drug – Drug interactions Lecture Pharmacokinetic level & Pharmacodynamic

level interactions with examples

112. Adverse Drug Reactions Lecture Examples/discussion of various types of

reactions

14

LIST OF PRACTICALS 2ND

YEAR BDS

PHARMACOLOGY

1. INTRODUCTION TO PHARMACOLOGY PRACTICALS:

Weights and measures

Definitions and conversions (metric system, imperial system)

Identification of apparatus

Routes of drug administration

Dosage form of drugs

2. PHARMACY:-

Carminative mixture

Sulphur ointment

KMnO4 solution

ORS

Saline expectorant

APC Powder

Castor oil emulsion

Bismuth chalk suspension

3. DOSE CALCULATIONs:-

Young’s formula:

Age /age + 12 X adult dose

Dilling’s formula:

Age/20 X adult dose

Clark’s formula:

Infant dose = weight in pounds/ 150 X adult dose

Calculation of half life, clearance and volume of distribution

Calculation of loading dose and maintenance dose

4. PRESCRIPTION WRITING:-

Tuberculosis, bacillary dysentery, amoebic dysentery, asariasis, tapeworm infection, ac.streptococcal

infection, pharyngitis, iron deficiency anemia, malaria, cerebral malaria, typhoid fever, bronchial asthma,

migraine, scabies, ccf, hypertension, watery diarrhea, allergic rhinitis

5. P-DRUGS:-

HTN with bronchial asthma, iron deficiency, allergic rhinitis, enteric fever, peptic ulcer, bacillary dysentery,

amoebic dysentery, tonic clonic epilepsy, parkinsonism, malaria, streptococcal pharyngitis, UTI, ac.gout,

ankylostomiasis, vaginal candiasis, bronchial asthma

15

LIST OF TUTORIALS

1. Pharmacokinetics

2. Pharmacodynamics

3. Parasympathomimetic

4. Parasympatholytics

5. NMJ

6. Sympathomimetics

7. Antihypertensive

8. Angina

16

REFERENCE BOOKS

1. Basic and Clinical Pharmacology (Bertram G.Katzung)

2. Pharmacology (Lippincott Illustrated Review)

3. A manual of Experimental Pharmacology and Pharmacy by Prof.Dr.Shabbir Ali Bhatti

17

Second Professional BDS Examination

Pharmacology & Therapeutics

Table of Specifications for Annual Professional Examination: Theory

Marks of Written Paper

Marks of Int. Asses

= 90

= 10

Total Time Allowed = 03 hrs

(Including MCQs)

Max Marks = 100 Date:

Pass Marks = 50

25 x MCQs (on separate sheet) (25 Marks) (Time = 30 min)

08 x SAQs/SEQs (C1 & C2) = 07 marks each

01 x SAQs/SEQs (C3) = 09 marks each (65 Marks) (Time = 2hrs 30 min)

S. No

Topic

No. of MCQs (25)

(C1=13, C2= 9, C3= 3)

01 mark each

No. of SAQs/SEQs (9)

• 08 x SAQs/SEQs (C1&C2)

= 07 marks each

• 01 x SAQs/SEQs (C3)

= 09 marks each

1. Gen Pharmacology 03 01

2. ANS 03 01

3. CNS 03 01

4. Local Anesthetics 02 01

5. Chemo 03 01

6. Opioids/NSAIDs 02 01

7. CVS/ Diuretics/Blood 03 01

8. Respiratory/GIT 03 01

9. Endocrinology 03 01

Total 25 (25 Marks) 09 (65 Marks)

Grand Total 90 marks

18

Internal Assessment Calculation (Theory Annual)

A B C D

Roll No. Name All Modules/

Pre annual Exams or any other exam

Total

Marks of internal

Assessment out of 10

Total Marks Sum of Marks obtained x 10 / sum of

total marks in all exams

Table of Specifications for Annual Professional Exam: Practical

VIVA

50 marks

Practical (OSPE + Practical Note Book) 40

marks

Total

Examiner 1 Examiner 2 OSPE Practical Notebook

25 Marks 25 Marks 35Marks 05 Marks 90 Marks

Internal Assessment Calculation (Practical)

A B C D

Roll No. Name OSPE/ PTT/ Class tests though out the year/

Pre annual Exams or any other exam

Total Marks of

internal assessment

Out of 10

Total Marks Sum of Marks obtained x 10 / sum of

total marks in all exams